Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MET-HIV Study: Metformin Versus Lifestyle Modification in People Living with HIV
TCTR20260215013Phase 4Recruiting
- Sponsor
- Nan Hospital
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in human immunodeficiency virus infection (HIV), cardiometabolic risk (CMR), sponsored by Nan Hospital. Started Feb 2026; status: recruiting.
02
Drugs
metformin
03
Conditions
human immunodeficiency virus infection (HIV)cardiometabolic risk (CMR)
Beyond the preview
Go deeper on TCTR20260215013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260215013.